Skip to main content

Table 8 Independent predictors of 30-day death in the statin previous users subset of patients with clinically suspected VAP and tracheal aspirate positive culture

From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

  Adjusted hazard ratio 95% CI P
Age 1.10 1.04-1.20 <0.01
SOFA day-1 value 1.24 1.06-1.46 <0.01
Statin continuation after ICU admission 0.30 0.11-0.81 0.02
  1. VAP, ventilator-associated pneumonia; CI, confidence interval; SOFA, sequential organ failure assessment; ICU, intensive care unit.